Cambridge biotech Agios Pharmaceuticals files for an IPO

Cambridge biotech Agios Pharmaceuticals files for an IPO
Agios Pharmaceuticals Inc. is the latest Massachusetts biotechnology company to explore an initial public stock offering this year. In a regulatory documents, Cambridge-based Agios said it is planning to move forward with an IPO. According to an …

The Best Kind of Biotech Dilution
The "d' word — dilution — gives biotech investors cold sweats at night. It can strike with little warning, leaving investors with devalued shares. Dilution is always better if avoided entirely, but it is a key source of funding for development-stage …
Read more on DailyFinance

US says unapproved biotech wheat appears limited to one field
With the U.S. wheat harvest in its early stages, the Washington State Grain Commission expressed "utmost urgency" for the USDA to spell out how it will find and isolate any biotech wheat among the tens of millions of bushels grown in the Northwest and …
Read more on Reuters

Leave a Reply